V

VERA

Vera Therapeutics, Inc.

22.58

0.93+4.30%
After Hours: 22.42  -0.16  -0.71%18:35 06/24 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

655.68M

175.55M

131.44M

83.75M

54.55M

Total Current Assets

651.22M

172.02M

125.70M

82.54M

54.26M

Total Non Current Assets

4.46M

3.52M

5.74M

1.21M

293.00K

Total Liabilities

78.53M

73.86M

54.53M

14.16M

4.33M

Total Current Liabilities

25.37M

22.30M

25.60M

7.69M

2.41M

Total Non Current Liabilities

53.16M

51.56M

28.93M

6.47M

1.92M

Total Equity

577.15M

101.69M

76.91M

69.59M

50.23M

Total Stockholders Equity

577.15M

101.69M

76.91M

69.59M

50.23M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

655.68M

175.55M

131.44M

83.75M

54.55M

Total Common Shares Outstanding

63.56M

44.45M

27.80M

20.97M

20.17M

Total Preferred Shares Outstanding

--

--

--

--

--